Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$7.82 - $12.44 $1.05 Million - $1.66 Million
-133,833 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$8.48 - $12.23 $127,064 - $183,254
-14,984 Reduced 10.07%
133,833 $1.26 Million
Q3 2020

Nov 16, 2020

SELL
$9.99 - $14.41 $93,906 - $135,454
-9,400 Reduced 5.94%
148,817 $1.63 Million
Q2 2020

Aug 14, 2020

SELL
$12.28 - $17.63 $978,716 - $1.41 Million
-79,700 Reduced 33.5%
158,217 $2.18 Million
Q1 2020

May 15, 2020

SELL
$11.31 - $18.26 $891,375 - $1.44 Million
-78,813 Reduced 24.88%
237,917 $3.16 Million
Q4 2019

Feb 14, 2020

BUY
$6.44 - $14.21 $402,500 - $888,125
62,500 Added 24.58%
316,730 $4.43 Million
Q3 2018

Nov 14, 2018

BUY
$4.07 - $6.25 $739,999 - $1.14 Million
181,818 Added 251.09%
254,230 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$5.0 - $7.14 $362,060 - $517,021
72,412
72,412 $505,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $10.1M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.